The Myth of the Designer Baby—Why ‘Genetic Optimization’ Is More Hype Than Science
By Arthur Caplan and James Tabery,
Scientific American
| 07. 28. 2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of traits like heart disease and cancer resistance, as well as intelligence, longevity, body mass index, baldness, eye color, hair color and left-handedness. It also promised to weed out what makes someone an alcoholic.
That left one commentator, a venture capitalist, feeling “nauseous.” Critics worried that it “treats children as marketable goods.” More than one reference to “designer babies” and “eugenics” naturally followed. “The GATTACA Future Is Here,” read one headline, referencing the classic sci-fi film from 1997 that imagined a dystopian future where genetically engineered “Valids” reign supreme over the “In-Valids” who were conceived the old-fashioned way.
As professional bioethicists, we would have those same concerns—if Nucleus Embryo actually did what it claims. But it doesn’t. The cinematic analogy to Nucleus Embryo isn’t GATTACA. It’s The Dropout...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
